| scholarly article | Q13442814 |
| P2093 | author name string | Shibata R | |
| Adachi A | |||
| Ogawa K | |||
| Higuchi I | |||
| Ishimoto A | |||
| Kiyomasu T | |||
| Kishida Y | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS) | Q22242256 | ||
| Complete nucleotide sequence of the AIDS virus, HTLV-III | Q28259080 | ||
| Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS | Q28262859 | ||
| Nucleotide sequence of the AIDS virus, LAV | Q28286313 | ||
| Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus | Q28299945 | ||
| Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
| The role of mononuclear phagocytes in HTLV-III/LAV infection | Q29618676 | ||
| Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. | Q30355613 | ||
| Effects of mutations within the 3' orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity | Q33929164 | ||
| DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells | Q34048204 | ||
| Genome organization and transactivation of the human immunodeficiency virus type 2. | Q34048704 | ||
| The trans-activator gene of HTLV-III is essential for virus replication | Q34161962 | ||
| A second post-transcriptional trans-activator gene required for HTLV-III replication | Q34162178 | ||
| Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS | Q34250436 | ||
| Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication | Q34603122 | ||
| In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity | Q36825840 | ||
| The art gene product of human immunodeficiency virus is required for replication | Q36827056 | ||
| Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus | Q37546388 | ||
| Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. | Q40126058 | ||
| A novel gene of HIV-1, vpu, and its 16-kilodalton product | Q42656133 | ||
| Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus | Q43563098 | ||
| The trans-activator gene of the human T cell lymphotropic virus type III is required for replication | Q44579665 | ||
| The sor gene of HIV-1 is required for efficient virus transmission in vitro | Q45831189 | ||
| Human immunodeficiency virus: the eighth gene | Q45831425 | ||
| Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group | Q45832109 | ||
| Complete nucleotide sequences of functional clones of the AIDS virus | Q45834378 | ||
| Human T lymphotropic virus type III infection of human alveolar macrophages. | Q45836633 | ||
| The HIV 'A' (sor) gene product is essential for virus infectivity | Q45847960 | ||
| Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients | Q45848343 | ||
| Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions | Q48367096 | ||
| Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). | Q48381924 | ||
| Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex | Q48427355 | ||
| Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome | Q48427365 | ||
| HTLV-III infection in brains of children and adults with AIDS encephalopathy | Q48536178 | ||
| Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR | Q68097623 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mutational analysis | Q1955810 |
| P304 | page(s) | 4110-4114 | |
| P577 | publication date | 1989-09-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Mutational analysis of the human immunodeficiency virus vpr open reading frame | |
| P478 | volume | 63 |
| Q35853370 | A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr. |
| Q40428153 | A defective HIV-1 vector for gene transfer to human lymphocytes |
| Q34501320 | A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. |
| Q35850368 | A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles |
| Q36249990 | A virion-specific inhibitory molecule with therapeutic potential for human immunodeficiency virus type 1 |
| Q41718191 | AIDS pathogenesis: the role of accessory gene mutations, leading to formation of long-lived persistently infected cells and/or apoptosis-inducing HIV-1 particles. |
| Q42538470 | Anticonvulsant phenytoinergic pharmacophores and anti-HIV activity--preliminary evidence for the dual requirement of the 4-aminophthalimide platform and the N-(1-adamantyl) substitution for antiviral properties |
| Q41646425 | Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells |
| Q40044520 | Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. |
| Q40930626 | Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes. |
| Q40853029 | Compatibility of Tat and Rev transactivators in the primate lentiviruses |
| Q40108853 | Complementation of the rev gene mutation among human and simian lentiviruses |
| Q35841354 | Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus |
| Q36698525 | Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency virus type 1 determinants |
| Q33936492 | Effect of reciprocal complementation of two defective human immunodeficiency virus type 1 (HIV-1) molecular clones on HIV-1 cell tropism and virulence |
| Q33938392 | Evolution of the primate lentiviruses: evidence from vpx and vpr |
| Q42809144 | Expression of heterologous genes from an IRES translational cassette in replication competent murine leukemia virus vectors. |
| Q41671911 | Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is rev-dependent and regulated by splicing |
| Q35832979 | Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. |
| Q35846506 | Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr |
| Q36013571 | Functional analysis of HIV1 and SIV Nef proteins |
| Q46612375 | Gag-Pol region determines the tropism of SIVagm for human cells |
| Q40105638 | Generation and characterization of infectious chimeric clones between human immunodeficiency virus type 1 and simian immunodeficiency virus from an African green monkey |
| Q45859881 | Generation and characterization of the human immunodeficiency virus type 1 mutants |
| Q40066880 | Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells |
| Q35067233 | HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivo |
| Q24682903 | HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle |
| Q37689513 | HIV-1 Vpr-a still "enigmatic multitasker". |
| Q37029922 | HIV-1 Vpr: mechanisms of G2 arrest and apoptosis |
| Q34957142 | HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention |
| Q24685157 | Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B |
| Q38609782 | Human immunodeficiency virus type 1 Vpr binds to the N lobe of the Wee1 kinase domain and enhances kinase activity for CDC2 |
| Q39880367 | Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest |
| Q24684302 | Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme |
| Q39874039 | Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. |
| Q33784862 | Human immunodeficiency virus type 1 induction mediated by genistein is linked to cell cycle arrest in G2 |
| Q36640545 | Human immunodeficiency virus type 1 infection of the brain |
| Q24685633 | Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity |
| Q36654319 | Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions |
| Q33801078 | Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation |
| Q41704642 | Human immunodeficiency virus type 1vif, vpr, andvpu mutants can produce persistently infected cells |
| Q41667836 | Human immunodeficiency virus type 2 vpx protein augments viral infectivity |
| Q37063467 | Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis |
| Q24649600 | Human immunodeficiency virus vpr product is a virion-associated regulatory protein |
| Q41712759 | Identification and localization of vpr gene product of human immunodeficiency virus type 1. |
| Q40281025 | Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity |
| Q40106491 | Identification of feline immunodeficiency virus rev gene activity |
| Q36820705 | Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac |
| Q39539630 | Impairment of human immunodeficiency virus type 1 (HIV-1) entry into Jurkat T cells by constitutive expression of the HIV-1 vpr protein: role of CD4 down-modulation |
| Q36770468 | Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. |
| Q35860937 | Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles |
| Q40044176 | Integration is essential for efficient gene expression of human immunodeficiency virus type 1. |
| Q24523667 | Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. |
| Q24645706 | Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein |
| Q37728093 | Macrophage signaling in HIV-1 infection |
| Q35403061 | Mechanism of action of regulatory proteins encoded by complex retroviruses |
| Q36636712 | Molecular biology of the human immunodeficiency virus accessory proteins |
| Q73584152 | Molecular characterization of HIV viruses generated after in vivo ligation |
| Q27022978 | Molecular mechanisms of HIV immune evasion of the innate immune response in myeloid cells |
| Q39209013 | Multiple determinants for growth of human immunodeficiency virus type 1 in monocyte-macrophages |
| Q34379227 | Mutagenesis of the putative alpha-helical domain of the Vpr protein of human immunodeficiency virus type 1: effect on stability and virion incorporation |
| Q35850945 | Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. |
| Q24684633 | Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr |
| Q36800949 | Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIV (AGM). |
| Q39872581 | Naturally occurring accessory gene mutations lead to persistent human immunodeficiency virus type 1 infection of CD4-positive T cells |
| Q93532181 | New nucleotide sequence data on the EMBL File Server |
| Q35890940 | Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. |
| Q44645285 | Nuclear localization of Vpr is crucial for the efficient replication of HIV-1 in primary CD4+ T cells |
| Q36793690 | Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein |
| Q34315689 | Pararetroviruses and retroviruses: a comparative review of viral structure and gene expression strategies. |
| Q41574533 | Persistently human immunodeficiency virus type 1-infected T cell clone expressing only doubly spliced mRNA exhibits reduced cell surface CD4 expression |
| Q34010283 | Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis |
| Q40756505 | Regulation of human immunodeficiency virus infection: implications for pathogenesis |
| Q35851550 | Regulatory genes of simian immunodeficiency viruses from west African green monkeys (Cercopithecus aethiops sabaeus) |
| Q36630330 | Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles |
| Q36683132 | Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products |
| Q37766007 | Roles of Vpr and Vpx in modulating the virus-host cell relationship |
| Q35882940 | Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1 |
| Q39079514 | The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention |
| Q45264878 | The HIV-1 Vpr displays strong anti-apoptotic activity |
| Q21245211 | The Vpr protein from HIV-1: distinct roles along the viral life cycle |
| Q40725617 | The genome of feline immunodeficiency virus. |
| Q28368083 | The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product |
| Q71828767 | The human immunodeficiency virus |
| Q24685965 | The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle |
| Q33849520 | The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages |
| Q40662335 | The molecular biology of HIV. Insights into pathogenesis and targets for therapy. |
| Q35838540 | The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles |
| Q41609512 | The role of the tnv protein and tnv RNA splicing signals in replication of HIV-1 IIIB isolates |
| Q40467649 | The vpr Regulatory Gene of HIV |
| Q34173884 | Using death to one's advantage: HIV modulation of apoptosis |
| Q40467618 | Viral Protein X |
| Q33601511 | Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers |
| Q33783972 | Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells |
| Q35859146 | Vpr-induced cell cycle arrest is conserved among primate lentiviruses. |
| Q26852313 | Yeast and the AIDS virus: the odd couple |
Search more.